Clonal evolution and the ‘survival of the nastiest’ remain the chief obstacles to curing cancer. But what if we could find a way to use the principles of evolution to beat evolving cancers cells at [more]
How is it possible to help patients decide on the best treatment option for them, when they are scared, and when there is such uncertainty? Elżbieta Senkus, a specialist in breast and prostate cancers, talks [more]
With increasing numbers of cancer drugs being approved on shorter trials that involve fewer patients, getting accurate reports of adverse events and side effects after approval is increasingly important. Maria Delaney reports on efforts to [more]
Stimulating development of more and better paediatric cancer drugs will be key to making progress, particularly in some of the hardest-to-treat childhood cancers. Gilles Vassal, past-President of the European Society for Paediatric Oncology, outlines emerging [more]
Bradford Hesse and colleagues explore insights gained from over a decade of data gathered by the US National Cancer Institute to monitor changes in the communication environment regarding cancer-related information. This is an abridged version [more]
Chemotherapy. That’s the word Jana Hermann doesn’t want to hear under any circumstances. She has breast cancer; she received the diagnosis four weeks ago. She underwent surgery to remove one of her breasts and five [more]
Anna Wagstaff looks at changes in the business, regulatory and science arenas that could open the way to delivering better cancer treatments, faster and cheaper. Of 91 new therapies approved for solid tumours between 2002 [more]
«We must abandon the fiction that current oversight systems are adequate to protect volunteers in first-in-human trials or to steward scientific efforts»: this is the strong conclusion of a paper published in Nature by two [more]
Umberto Veronesi passed away on the 8th of November 2016, at the end of a career dedicated to fighting cancer. During his long and productive life he made significant contributions to improving cancer care and [more]
The risk of developing breast cancer varies widely from woman to woman in ways we are increasingly able to define. Marc Beishon asks: Is it time to move to population screening for risk, and tailor mammography schedules – [more]
Evidence-based medicine is the cornerstone of medical practice, and yet clinicians are rarely offered training in the tricky business of finding, evaluating and making sense of the evidence they need. Anna Rouillard reports on an [more]
The European Commission has issued a warning about a 1 million projected shortfall in Europe’s clinical workforce by 2020 – with nursing shortages accounting for more than half the total. Marc Beishon reports on the [more]
Engaging the body’s own immune system in controlling cancer has long been an aspiration for cancer researchers and clinicians. This overview looks at progress towards that goal, and how it is changing the paradigm of [more]